CN104364256A - 降伊波加因碱的立体选择性全合成 - Google Patents

降伊波加因碱的立体选择性全合成 Download PDF

Info

Publication number
CN104364256A
CN104364256A CN201280058362.5A CN201280058362A CN104364256A CN 104364256 A CN104364256 A CN 104364256A CN 201280058362 A CN201280058362 A CN 201280058362A CN 104364256 A CN104364256 A CN 104364256A
Authority
CN
China
Prior art keywords
compound
formula
conditions
group
noribogaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280058362.5A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特·M·莫里亚蒂
德博拉·C·马什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DemeRx Inc
Original Assignee
DemeRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DemeRx Inc filed Critical DemeRx Inc
Publication of CN104364256A publication Critical patent/CN104364256A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201280058362.5A 2011-12-08 2012-12-03 降伊波加因碱的立体选择性全合成 Pending CN104364256A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568568P 2011-12-08 2011-12-08
US61/568,568 2011-12-08
PCT/US2012/067629 WO2013085850A2 (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Publications (1)

Publication Number Publication Date
CN104364256A true CN104364256A (zh) 2015-02-18

Family

ID=48575047

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280058362.5A Pending CN104364256A (zh) 2011-12-08 2012-12-03 降伊波加因碱的立体选择性全合成

Country Status (10)

Country Link
US (2) US8937061B2 (enExample)
EP (1) EP2788355A4 (enExample)
JP (1) JP2015509076A (enExample)
CN (1) CN104364256A (enExample)
CA (2) CA3122767C (enExample)
HK (1) HK1204604A1 (enExample)
IL (1) IL232724A (enExample)
IN (1) IN2014CN04160A (enExample)
WO (1) WO2013085850A2 (enExample)
ZA (1) ZA201403995B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
MX2013000733A (es) 2010-07-23 2013-05-30 Demerx Inc Composiciones de noribogaina.
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine
WO2013112757A1 (en) * 2012-01-25 2013-08-01 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
AU2013212139A1 (en) * 2012-01-25 2014-06-26 Demerx, Inc. Synthetic voacangine
WO2014098877A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
CA3256416A1 (en) 2013-03-15 2025-06-21 Demerx, Inc. METHOD FOR THE TREATMENT OF ADDICTION IN PATIENTS UNDER METHADONE WITH NORIBOGAINE
KR20160120781A (ko) 2014-02-18 2016-10-18 데메알엑스, 인크. 약물 중독의 급성 및 장기간 치료 방법
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9345711B2 (en) 2014-02-18 2016-05-24 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
PT3223906T (pt) 2014-11-26 2021-05-05 Demerx Inc Métodos e composições para potencializar a ação de analgésicos de opioides usando alcaloides de iboga
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US20240100061A1 (en) 2022-09-14 2024-03-28 The Board Of Trustees Of The Leland Stanford Junior University Compositions of Iboga Alkaloids and Methods of Treatment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100311725A1 (en) * 1997-09-04 2010-12-09 Demerx, Inc. Noribogaine in the treatment of pain and drug addiction
CN102225937A (zh) * 2011-05-04 2011-10-26 中国科学院昆明植物研究所 抗肿瘤生物碱类化合物,其药物组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813873A (en) * 1957-11-19 Derivatives of the ibogaine alkaloids
US3639408A (en) * 1967-06-03 1972-02-01 Shionogi & Co Process for the preparation of isoquinuclidine derivatives
AU4613296A (en) 1994-07-25 1996-04-19 Nda International, Inc. A method of treating chemical dependency in mammals and a composition therefor
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US7220737B1 (en) * 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100311725A1 (en) * 1997-09-04 2010-12-09 Demerx, Inc. Noribogaine in the treatment of pain and drug addiction
CN102225937A (zh) * 2011-05-04 2011-10-26 中国科学院昆明植物研究所 抗肿瘤生物碱类化合物,其药物组合物及其制备方法和应用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARRY M. TROST等,: ""A Total Synthesis of Racemic and Optically Active Ibogamine. Utilization and Mechanism of a New Silver Ion Assisted Palladium Catalyzed Cyclization"", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 *
DAVID M. HODGSON等,: ""Enantioselective Access to Isoquinuclidines by Tropenone Desymmetrization and Homoallylic Radical Rearrangement: Synthesis of (+)-Ibogamine"", 《ORG. LETT.》 *
杨秀伟等,: ""44种生物碱类化合物对人鼻咽癌细胞株KB和人白血病细胞株HL-60细胞增殖抑制活性的筛选"", 《中国现代中药》 *

Also Published As

Publication number Publication date
WO2013085850A3 (en) 2014-12-18
US8937061B2 (en) 2015-01-20
HK1204604A1 (en) 2015-11-27
EP2788355A2 (en) 2014-10-15
US20130165647A1 (en) 2013-06-27
WO2013085850A2 (en) 2013-06-13
CA3122767C (en) 2023-03-28
US9403837B2 (en) 2016-08-02
CA2856551C (en) 2021-06-22
IL232724A (en) 2017-07-31
CA2856551A1 (en) 2013-06-13
JP2015509076A (ja) 2015-03-26
CA3122767A1 (en) 2013-06-13
EP2788355A4 (en) 2015-10-21
IL232724A0 (en) 2014-08-03
IN2014CN04160A (enExample) 2015-07-17
ZA201403995B (en) 2016-09-28
US20150005492A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
CN104364256A (zh) 降伊波加因碱的立体选择性全合成
KR20110134510A (ko) 오피오이드의 신규한 디카르복실산 연결 아미노산 및 펩티드 프로드러그와 그 용도
JP2002525371A (ja) Cgrpリガンドとしてのベンゾイミダゾリニルピペリジン
RS55812B1 (sr) Metilfenidatni prolekovi, procesi za njihovo dobijanje i njihova primena
IL91452A (en) Beta-carbolines,their bioisosteric benzofuran and benzothiophene analogues,their preparation and cytostatic compositions containing them
BRPI0619705A2 (pt) composto, composição farmacêutica, método para ligar receptores a opióide num paciente, método para tratar disfunção gastrointestinal, método para tratar ìleo, método para tratar obesidade, método para tratar um efeito colateral associado com um opióide composto e método para tratar dor
JP2004500351A (ja) ノシセプチン受容体親和性を有するトリアゾスピロ化合物
KR0151114B1 (ko) (-)-리토드린
US9463187B2 (en) Methylphenidate derivatives and uses of them
Czarnocki et al. Selected recent advances in the stereoselective synthesis of isoquinoline and β-carboline derivatives with the use of chiral auxiliaries of natural origin
Henkel et al. Stereochemical studies on medicinal agents. 21. Investigation of the role of conformational factors in the action of diphenylpropylamines. Synthesis and analgetic potency of 5-methylmethadone diastereomers
US6984664B2 (en) Tertiary amino compounds having opioid receptor affinity
CN113024557B (zh) 一种Peganumine A生物碱结构简化物及其应用
Ramakrishnan et al. Synthesis and biological evaluation of a metazocine-containing enkephalinamide. Evidence for nonidentical roles of the tyramine moiety in opiates and opioid peptides
WO2022235927A1 (en) Novel tryptamines and methods of treating mood disorders
AU2010214685C1 (en) Noribogaine compositions
AU2012202509B2 (en) Noribogaine compositions
WO1993007871A1 (en) Methods for the treatment of hyperlipidemia using azaspiranes
US3687937A (en) 1,5-methano-3-benzazocine derivatives
JP2021066690A (ja) オピオイドペプチド誘導体及びこれを含む医薬組成物
ES2426915T3 (es) Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas
EP4561699A1 (en) Selective opioid receptor agonists and antagonists
US5455247A (en) Methods for the treatment of hyperlipidemia using azaspiranes
WO1994009007A1 (en) 3a,6-bridged octahydroisoindoles and related hydroisoquinolines and hydrobenzazepines and their use as pharmaceutical and radioimaging agents
CA2146000A1 (en) 3,3-disubstituted tri-and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150218